Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (NCT07890168) titled 'Integrated Assessment of Immune-Inflammatory and Metabolic Biomarkers for Prediction of Coronary No-Reflow Following Primary PCI in STEMI Patients' on Oct. 18.
Study Type: Observational
Primary Sponsor: Sohag University
Condition:
Integrated Assessment
Immune-Inflammatory
Metabolic Biomarkers
Coronary No-Reflow
Primary Percutaneous Coronary Intervention
ST Segment Elevation Myocardial Infarction
Intervention:
Diagnostic Test: Assessment of immune-inflammatory and metabolic biomarkers
Recruitment Status: Recruiting
Date of First Enrollment: September 1, 2026
Target Sample Size: 400
Countries of Recruitment:...